Valuation: Progyny, Inc.

Market Cap 2.31B 2.03B 1.86B 1.74B 3.28B 219B 3.34B 22.42B 8.69B 108B 8.66B 8.47B 375B P/E 2026 *
22.7x
P/E 2027 * 19.9x
Enterprise Value 2.14B 1.88B 1.73B 1.61B 3.04B 203B 3.1B 20.79B 8.05B 99.81B 8.03B 7.86B 347B EV / Sales 2026 *
1.55x
EV / Sales 2027 * 1.29x
Free-Float
76.71%
Yield 2026 *
-
Yield 2027 * -
1 day+2.15%
1 week+9.52%
Current month+2.15%
1 month+12.40%
3 months+74.67%
6 months+14.68%
Current year+14.68%
1 week 27.25
Extreme 27.25
30.1
1 month 24.7
Extreme 24.7
30.1
Current year 16.1
Extreme 16.1
30.1
1 year 16.1
Extreme 16.1
30.1
3 years 13.39
Extreme 13.39
44.95
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
Manager TitleAgeSince
Chief Executive Officer 58 2021-12-31
Director of Finance/CFO 60 2020-09-14
Chief Operating Officer 56 2025-04-16
Director TitleAgeSince
Chairman 66 2021-12-31
Director/Board Member 77 2016-12-15
Director/Board Member 58 2021-12-31
Date Insider Type Main position Quantity % Market Cap.
06-16Tax

Executive/Senior Manager

-819 0.0010%
06-03Tax

General Counsel

-938 0.0012%
06-03Tax

Chief Financial Officer

-2,856 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
+2.15%+9.52%+33.50%-25.14% 2.31B
+2.62%+5.11%+30.78%-11.26% 387B
+7.62%+8.38%+5.16%-6.32% 90.38B
+0.50%-0.86%-17.14%-1.26% 73.29B
+3.07%+13.21%+62.10%-8.43% 49.16B
+6.48%+8.54%+20.65%+1.33% 33.75B
+1.68%+15.46%-24.08%-22.80% 12.11B
+0.84%+10.70%+68.97%+317.57% 4.96B
+2.86%+3.45%+96.00%+500.82% 2.84B
Average +3.09%+5.36%+30.66%+82.72% 72.91B
Weighted average by Cap. +3.27%+1.63%+23.29%-4.16%

Financials

2026 *2027 *
Net sales 1.38B 1.21B 1.12B 1.04B 1.96B 131B 2B 13.44B 5.21B 64.52B 5.19B 5.08B 225B 1.5B 1.32B 1.22B 1.13B 2.14B 143B 2.18B 14.62B 5.67B 70.21B 5.65B 5.53B 244B
Net income 109M 95.64M 88.03M 82.03M 155M 10.36B 158M 1.06B 410M 5.08B 409M 400M 17.69B 125M 110M 101M 94.49M 178M 11.93B 182M 1.22B 473M 5.86B 471M 461M 20.38B
Net Debt -168M -148M -136M -127M -239M -15.98B -244M -1.63B -633M -7.85B -631M -618M -27.3B -359M -315M -290M -270M -510M -34.13B -520M -3.49B -1.35B -16.75B -1.35B -1.32B -58.31B
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
846
Date Price Change Volume
26-07-01 US$29.45 +2.15% 1,498,844
26-06-30 US$28.83 -0.10% 1,259,896
26-06-29 US$28.86 +1.23% 1,279,370
26-06-26 US$28.51 +4.13% 1,597,353
26-06-25 US$27.38 +1.82% 795,541
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
29.45USD
Average target price
30.00USD
Spread / Average Target
+1.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGNY Stock